We are live on ! Find out more
EEG

E.E. Geduld Portfolio holdings

AUM $178M
1-Year Est. Return 29.34%
This Fund
S&P 500
This Quarter Est. Return
-7.61%
1 Year Est. Return
+29.34%
3 Year Est. Return
+59.91%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$107M
AUM Growth
-$54.2M
Cap. Flow
-$24M
Cap. Flow %
-22.49%
Top 10 Hldgs %
54.93%
Holding
347
New
45
Increased
19
Reduced
60
Closed
132
Avg Time Held Equity + Options
4.4 quarters
Top 10 Avg Time Held Equity + Options
2.2 quarters
Top 20 Avg Time Held Equity + Options
2.4 quarters
Avg Time Held Equity only
4.6 quarters
Top 10 Avg Time Held Equity only
3.6 quarters
Top 20 Avg Time Held Equity only
3.2 quarters

Sector Composition

Rank Sector Weight
1 Financials 45.84%
2 Miscellaneous 25.05%
3 Healthcare 9.93%
4 Consumer Discretionary 6.85%
5 Technology 4.09%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow Held Since
DVOX
151
DELISTED
DYNAVOX INC CL A COM STK (DE)
DVOX
$6K 0.01%
150,000
– –
2013 Q2
9 quarters
GM.WS.C icon
152
DELISTED
GENERAL MTRS CO WTS EXP 12/31/15 (DE)
GM.WS.C
$5K ﹤0.01%
105,000
– –
2013 Q3
8 quarters
GBSN
153
DELISTED
GREAT BASIN SCIENTIFIC INC COM PAR $.0001 NEW
GBSN
– –
0
– –
2015 Q3
0 quarters
ROIQW
154
DELISTED
ROI ACQUISITION CORP WT EXP 2/28/2017 (DE)
ROIQW
$4K ﹤0.01%
+10,000
New +$4K
2015 Q3
0 quarters
IGC.WS icon
155
DELISTED
INDIA GLOBALIZATION CAPITAL, INC. WTS EXP 3/06/2017
IGC.WS
$1K ﹤0.01%
157,798
– –
2013 Q2
9 quarters
C.WS.B icon
156
DELISTED
CITIGROUP INC WTS EXP (10/28/2018) (DE)
C.WS.B
$1K ﹤0.01%
50,000
– –
2013 Q2
9 quarters
AMRN icon
157
Amarin Corp
AMRN
$244M
– –
-1,250
Closed -$62K –
APYX icon
158
Apyx Medical
APYX
$112M
– –
-25,000
Closed -$70K –
AROC icon
159
Archrock
AROC
$5.32B
– –
-15,000
Closed -$490K –
BLUE icon
160
DELISTED
bluebird bio
BLUE
– –
-801
Closed -$1.75M –
BOOT icon
161
Boot Barn
BOOT
$3.63B
– –
-7,500
Closed -$240K –
BPOP icon
162
Popular Inc
BPOP
$9.98B
– –
-7,000
Closed -$202K –
BURL icon
163
Burlington
BURL
$16.8B
– –
-7,500
Closed -$384K –
CLDX icon
164
Celldex Therapeutics
CLDX
$2.31B
– –
-667
Closed -$252K –
CMG icon
165
CALL
Chipotle Mexican Grill
CMG
$38.5B
– –
-500,000
Closed -$6.05M –
CPRI icon
166
Capri Holdings
CPRI
$1.72B
– –
-20,000
Closed -$842K –
CRDF icon
167
Cardiff Oncology
CRDF
$80.9M
– –
-139
Closed -$102K –
CROX icon
168
Crocs
CROX
$5.6B
– –
-20,000
Closed -$294K –
CTRA icon
169
CALL
DELISTED
Coterra Energy
CTRA
– –
-20,000
Closed -$631K –
CVGW icon
170
DELISTED
Calavo Growers
CVGW
– –
-5,000
Closed -$260K –
CVLT icon
171
CALL
Commault Systems
CVLT
$6.44B
– –
-10,000
Closed -$424K –
DSX icon
172
Diana Shipping
DSX
$357M
– –
-28,607
Closed -$141K –
DXCM icon
173
DexCom
DXCM
$32.4B
– –
-20,000
Closed -$400K –
EOG icon
174
EOG Resources
EOG
$78.9B
– –
-5,000
Closed -$438K –
EQT icon
175
EQT Corp
EQT
$33.3B
– –
-4,593
Closed -$203K –

Similar funds

E.E. Geduld's Q3 2015 Portfolio in Review

As of Q3 2015, E.E. Geduld held 347 positions worth $107M, down 34% from $161M the previous quarter. Its ten largest holdings account for 55% of the portfolio.

E.E. Geduld withdrew a net $24M in Q3 2015, closing 132 positions and reducing 60 holdings. Its most notable exit was bluebird bio, an estimated $1.75M position sold in full.

By sector, the portfolio is most concentrated in Financials at 46% of assets, up from 33% a quarter earlier, followed by Miscellaneous and Healthcare.

Against the trend, E.E. Geduld opened a new position in Bristol-Myers Squibb worth $1.48M.

  • E.E. Geduld's largest Q3 2015 buy was Bristol-Myers Squibb: 25,000 shares worth $1.48M.
  • E.E. Geduld added most to Amazon in Q3 2015, an estimated $758K increase.
  • E.E. Geduld's biggest Q3 2015 reduction was Ariad Pharmaceuticals Inc, cutting an estimated $578K.
  • E.E. Geduld fully exited bluebird bio in Q3 2015, selling an estimated $1.75M.
  • E.E. Geduld's ten largest holdings make up 55% of its $107M portfolio in Q3 2015.
  • E.E. Geduld opened 45 new positions and closed 132 in Q3 2015.
  • E.E. Geduld's portfolio value fell 34% quarter-over-quarter to $107M.

Based on E.E. Geduld's 13F filing for Q3 2015, filed 6 Nov 2015.